Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue

被引:17
作者
NievesCruz, B
Rivera, A
Cifuentes, J
Pataki, G
Matalon, S
Carlo, WA
Tanswell, AK
Freeman, B
机构
[1] UNIV ALABAMA, DEPT ANESTHESIOL, BIRMINGHAM, AL 35233 USA
[2] UNIV ALABAMA, DEPT PEDIAT, BIRMINGHAM, AL 35233 USA
[3] UNIV ALABAMA, DEPT BIOCHEM & MOLEC GENET, BIRMINGHAM, AL 35233 USA
[4] UNIV ALABAMA, DEPT PHYSIOL & BIOPHYS, BIRMINGHAM, AL 35233 USA
[5] UNIV TORONTO, DEPT PAEDIAT, TORONTO, ON M5G 1X8, CANADA
关键词
minimum surface tension; antioxidant enzymes; alveolar distribution; superoxide dismutase;
D O I
10.1152/ajplung.1996.270.4.L659
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pulmonary surfactant mixtures are rapidly taken up by alveolar type II cells and thus may serve as vectors for the pulmonary delivery of antioxidant enzymes to the alveolar epithelium. We prepared emulsions of Survanta with superoxide dismutase (CuZn-SOD) and catalase and quantified their cellular uptake both in vitro and in vivo. Incubations of fetal lung epithelial cells with an emulsion of Survanta plus SOD and catalase mixtures resulted in significant augmentation of SOD and catalase activities (12.8 +/- 4.6 U SOD/mu g DNA; 7.49 +/- 2.21 U catalase/mu g DNA). These numbers were significantly greater than those obtained in controls (1.8 U SOD/mu g DNA; 0.55 +/- 0.52 U catalase/mu g DNA), Survanta alone (0.43 U SOD/mu g DNA; 0.16 U catalase/mu g DNA), and SOD and catalase alone (3.47 +/- 5.2 U SOD/mu g DNA; 4.24 +/- 3.0 U catalase/mu g DNA). Intratracheal instillation of the Survanta plus SOD and catalase mixture resulted in significant augmentation of enzymes by the rat lung homogenates. Confocal microscopic analysis revealed the presence of antioxidant enzymes in the cytoplasm of epithelial cells. We concluded that Survanta supplementation, in addition to replenishing surfactant stores, can also enhance the delivery of antioxidant enzymes to alveolar epithelium both in vitro and in vivo.
引用
收藏
页码:L659 / L667
页数:9
相关论文
共 43 条
[1]   QUANTITATION OF ALVEOLAR DISTRIBUTION OF LIPOSOME-ENTRAPPED ANTIOXIDANT ENZYMES [J].
BAKER, RR ;
CZOPF, L ;
JILLING, T ;
FREEMAN, BA ;
KIRK, KL ;
MATALON, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05) :L585-L594
[2]  
BANCALARI E, 1986, PEDIATR CLIN N AM, V33, P1
[3]   MECHANISMS OF EXTRACELLULAR REACTIVE OXYGEN SPECIES INJURY TO THE PULMONARY MICROVASCULATURE [J].
BARNARD, ML ;
MATALON, S .
JOURNAL OF APPLIED PHYSIOLOGY, 1992, 72 (05) :1724-1729
[4]   MITIGATION OF OXIDANT INJURY TO LUNG MICROVASCULATURE BY INTRATRACHEAL INSTILLATION OF ANTIOXIDANT ENZYMES [J].
BARNARD, ML ;
BAKER, RR ;
MATALON, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :L340-L345
[5]   PHARMACOTHERAPY IN BRONCHOPULMONARY DYSPLASIA [J].
BLANCHARD, PW ;
BROWN, TM ;
COATES, AL .
CLINICS IN PERINATOLOGY, 1987, 14 (04) :881-910
[6]   SPATIAL AND TEMPORAL DIFFERENCES IN FIBROBLAST BEHAVIOR IN FETAL-RAT LUNG [J].
CANIGGIA, I ;
TSEU, I ;
HAN, RNN ;
SMITH, BT ;
TANSWELL, K ;
POST, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06) :L424-L433
[7]   BIOCHEMICAL ASSAYS IN LUNG HOMOGENATES - ARTIFACTS CAUSED BY TRAPPED BLOOD AFTER PERFUSION [J].
CROSS, CE ;
WATANABE, TT ;
HASEGAWA, GK ;
GORALNIK, GN ;
ROERTGEN, KE ;
KAIZU, T ;
REISER, KM ;
GORIN, AB ;
LAST, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 48 (01) :99-109
[8]   PHARMACOLOGICAL INTERACTIONS OF EXOGENOUS LUNG SURFACTANT AND RECOMBINANT HUMAN CU ZN SUPEROXIDE-DISMUTASE [J].
DAVIS, JM ;
ROSENFELD, WN ;
KOO, HC ;
GONENNE, A .
PEDIATRIC RESEARCH, 1994, 35 (01) :37-40
[9]   PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT [J].
ENHORNING, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) :198-203
[10]  
EVANS H E, 1986, Journal of Free Radicals in Biology and Medicine, V2, P369, DOI 10.1016/S0748-5514(86)80038-1